JP2018533974A5 - - Google Patents

Download PDF

Info

Publication number
JP2018533974A5
JP2018533974A5 JP2018536331A JP2018536331A JP2018533974A5 JP 2018533974 A5 JP2018533974 A5 JP 2018533974A5 JP 2018536331 A JP2018536331 A JP 2018536331A JP 2018536331 A JP2018536331 A JP 2018536331A JP 2018533974 A5 JP2018533974 A5 JP 2018533974A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
sequence
protein
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018533974A (ja
JP7037486B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2016/050316 external-priority patent/WO2017054831A1/en
Publication of JP2018533974A publication Critical patent/JP2018533974A/ja
Publication of JP2018533974A5 publication Critical patent/JP2018533974A5/ja
Application granted granted Critical
Publication of JP7037486B2 publication Critical patent/JP7037486B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536331A 2015-10-01 2016-09-30 医薬としてのヒト由来免疫抑制タンパク質およびペプチドの使用 Expired - Fee Related JP7037486B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201570620 2015-10-01
DKPA201570620 2015-10-01
DKPA201670634 2016-08-23
DKPA201670634 2016-08-23
PCT/DK2016/050316 WO2017054831A1 (en) 2015-10-01 2016-09-30 Use of human derived immunosuppressive proteins and peptides as medicaments

Publications (3)

Publication Number Publication Date
JP2018533974A JP2018533974A (ja) 2018-11-22
JP2018533974A5 true JP2018533974A5 (enExample) 2019-10-03
JP7037486B2 JP7037486B2 (ja) 2022-03-16

Family

ID=57144698

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536331A Expired - Fee Related JP7037486B2 (ja) 2015-10-01 2016-09-30 医薬としてのヒト由来免疫抑制タンパク質およびペプチドの使用

Country Status (6)

Country Link
US (1) US20190040106A1 (enExample)
EP (1) EP3356389A1 (enExample)
JP (1) JP7037486B2 (enExample)
CN (1) CN108368155A (enExample)
CA (1) CA2999792A1 (enExample)
WO (1) WO2017054831A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019528071A (ja) * 2016-08-23 2019-10-10 エイムヴィオン・アクティエセルスカブAimVion A/S 新規免疫刺激ペプチド
JP7277466B2 (ja) * 2017-09-01 2023-05-19 インプラザー エー・ペー・エス 疾患の予防および/または治療における使用のためのワクチン
US11352421B2 (en) 2018-12-11 2022-06-07 Rush University Medical Center Treatment for adverse immune reaction to metal implant debris

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048763A1 (en) * 2000-02-04 2002-04-25 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis
WO2004087748A1 (en) * 2003-04-04 2004-10-14 Centre National De La Recherche Scientifique Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
WO2005095442A1 (en) * 2004-03-30 2005-10-13 Institut Gustave Roussy Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
WO2009106073A2 (en) * 2008-02-28 2009-09-03 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
EP2550529B1 (en) * 2010-03-23 2021-11-17 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding

Similar Documents

Publication Publication Date Title
JP7128246B2 (ja) 抗炎症活性を有するペプチド、及びそれを含む組成物
Emili et al. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD
CN112105633A (zh) 新型白介素2及其用途
JP2016533709A5 (enExample)
JP2013513377A5 (enExample)
CN107001438A (zh) 白细胞介素‑15组合物及其用途
JP2015212284A5 (enExample)
JP2020501550A5 (enExample)
JP2018533974A5 (enExample)
JP2010501191A5 (enExample)
RU2010122053A (ru) Иммуносупрессорные полипептиды и нуклеиновые кислоты
JP2015525217A5 (enExample)
JP2019500414A5 (enExample)
EP1797118A2 (en) Protease resistant human and non-human hmgb1 box-a mutants and their therapeutic/diagnostic use
JP2017522325A5 (enExample)
HRP20180950T1 (hr) Jednolančani agonistički proteini trail receptora
JP2014510519A5 (enExample)
JP2017514522A5 (enExample)
JP2018504911A5 (enExample)
JP2008506357A5 (enExample)
JP2012508698A5 (enExample)
FI2956471T3 (fi) Il-1-beetan estäjän koostumus ja sen käyttö
JP2021518151A5 (enExample)
JP2016503434A5 (enExample)
WO2017149311A1 (en) Evasins for use in therapy and diagnostics